• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Ascensia Diabetes Care Partners With VisiQuate to Expand Beyond Blood Glucose Monitoring

by Jasmine Pennic 09/23/2020 Leave a Comment

Ascensia Diabetes Care Partners With VisiQuate to Expand Beyond Blood Glucose Monitoring

What You Should Know:

– Ascensia Diabetes Care and VisiQuate announced a partnership to expand beyond blood glucose monitoring and provide holistic diabetes management solutions.

– The overall solution will provide integration with Ascensia’s existing devices and digital diabetes solutions to enable it to capture data from patients who have consented to provide their information.


Ascensia Diabetes Care, a Santa Rosa, CA-based provider of blood glucose monitoring systems (BGMS) is teaming up with VisiQuate, a healthcare analytics company on their digital diabetes management platform. The strategic partnership will serve as a key element of their strategy to expand beyond blood glucose monitoring and provide holistic diabetes management solutions.

Integration Details

The overall solution will provide integration with Ascensia’s existing devices and digital diabetes solutions to enable it to capture data from patients who have consented to provide their information. The platform will then provide analytics for contracted health plan clients, analytics and engagement for involved providers, and internal analytics to support Ascensia’s business operations. It will also include a diabetes educator platform.

“The future of diabetes management is more than just using devices and medications. Collecting and analyzing data to provide actionable personalized management recommendations will be critical to improving the health and lives of people with diabetes. We believe in the importance of building a robust data platform that can enable us to capture data and offer management solutions for patients, physicians and health plans,” explained Martin Gerber, Global Head of Innovation, Ascensia Diabetes Care. “We looked at a great number of patient-centric solutions in this space and saw that VisiQuate’s HealthMobile.D solution and data platform was the best option to support our data strategy. We are excited to be working with a market leader in this field to implement this new platform for our business and offer a new data driven option for people with diabetes.”

Tagged With: Ascensia Diabetes Care, Blood Glucose Monitor, diabetes, Diabetes Management, digital diabetes management platform, Digital Diabetes Platform, Partners, physicians

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |